Get up to $100 for a study visit

New York City NY

Description

Columbia Research Unit and Project Achieve are conducting a phase 3 HIV vaccine efficacy study called the Mosaico study. The Mosaico study aims to enroll 3,800 people in the United States, South America, and Europe. The Mosaico study will include • HIV-negative gay men, transgender people, and gender non-conforming individuals, • who are NOT on PrEP, and • who are from 18-60 years old. • You can't get HIV from the test vaccines and antibodies. Participants will be compensated up to $100 for a study visit. Studies have multiple visits. Click on to find out if you meet basic criteria.